JP2023542279A5 - - Google Patents
Info
- Publication number
- JP2023542279A5 JP2023542279A5 JP2023512665A JP2023512665A JP2023542279A5 JP 2023542279 A5 JP2023542279 A5 JP 2023542279A5 JP 2023512665 A JP2023512665 A JP 2023512665A JP 2023512665 A JP2023512665 A JP 2023512665A JP 2023542279 A5 JP2023542279 A5 JP 2023542279A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010705069.XA CN113952472A (zh) | 2020-07-21 | 2020-07-21 | 用于治疗眼部疾病的组合物和方法 |
| PCT/IB2021/000509 WO2022018518A1 (en) | 2020-07-21 | 2021-07-20 | Compositions and methods for the treatment of eye diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023542279A JP2023542279A (ja) | 2023-10-06 |
| JPWO2022018518A5 JPWO2022018518A5 (https=) | 2024-07-26 |
| JP2023542279A5 true JP2023542279A5 (https=) | 2024-07-26 |
Family
ID=79459955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512665A Pending JP2023542279A (ja) | 2020-07-21 | 2021-07-20 | 眼疾患の処置のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230321281A1 (https=) |
| EP (1) | EP4185319A4 (https=) |
| JP (1) | JP2023542279A (https=) |
| CN (2) | CN113952472A (https=) |
| AU (1) | AU2021312379A1 (https=) |
| CA (1) | CA3186826A1 (https=) |
| WO (1) | WO2022018518A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11345930B2 (en) * | 2020-09-02 | 2022-05-31 | 4D Molecular Therapeutics Inc. | Codon optimized RPGRORF15 genes and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2507036A1 (en) * | 2002-12-02 | 2004-06-17 | Genvec, Inc. | Materials and methods for treating ocular-related disorders |
| EP2872183B1 (en) * | 2012-07-11 | 2018-09-26 | The Trustees Of The University Of Pennsylvania | Aav-mediated gene therapy for rpgr x-linked retinal degeneration |
| JP5971661B2 (ja) * | 2012-09-19 | 2016-08-17 | 国立大学法人 東京大学 | 神経活動依存的プロモータ活性を有するｄｎａ、及びこれを含むベクター |
| EP3030665B9 (en) * | 2013-08-05 | 2023-10-04 | Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum | Recombinant aav-crumbs homologue composition and methods for treating lca-8 and progressive rp |
| AU2014359136B2 (en) * | 2013-12-06 | 2020-06-25 | Centre Hospitalier Universitaire De Montpellier | Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subject |
| CA2945965C (en) | 2014-04-15 | 2022-11-01 | Applied Genetic Technologies Corporation | Codon optimized nucleic acid encoding a retinitis pigmentosa gtpase regulator (rpgr) |
| IL248102B (en) * | 2014-05-02 | 2022-07-01 | Genzyme Corp | aav vectors for gene therapy of the central nervous system and retina |
| US20160346359A1 (en) * | 2015-05-01 | 2016-12-01 | Spark Therapeutics, Inc. | Adeno-associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease |
| GB201516066D0 (en) * | 2015-09-10 | 2015-10-28 | Young & Co Llp D | Treatment of retinitis pigmentosa |
| EP3827812B1 (en) * | 2016-07-29 | 2025-10-29 | The Regents of the University of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| WO2019006182A1 (en) * | 2017-06-30 | 2019-01-03 | The Regents Of The University Of California | VIRIONS OF ADENO-ASSOCIATED VIRUSES OF CAPSID VARIANTS AND METHODS OF USE THEREOF |
| MX2020007876A (es) * | 2018-01-31 | 2020-12-03 | Res Inst Nationwide Childrens Hospital | Terapia genica para la distrofia muscular de cinturas tipo 2c. |
| TW202028225A (zh) * | 2018-09-21 | 2020-08-01 | 英商夜星克有限公司 | 用於治療色素性視網膜炎之組合物及方法 |
| EP4087617A4 (en) * | 2020-01-10 | 2024-05-01 | Solid Biosciences Inc. | VIRAL VECTOR FOR COMBINATION THERAPY |
-
2020
- 2020-07-21 CN CN202010705069.XA patent/CN113952472A/zh active Pending
-
2021
- 2021-07-20 WO PCT/IB2021/000509 patent/WO2022018518A1/en not_active Ceased
- 2021-07-20 CN CN202180064480.6A patent/CN116615552A/zh active Pending
- 2021-07-20 JP JP2023512665A patent/JP2023542279A/ja active Pending
- 2021-07-20 AU AU2021312379A patent/AU2021312379A1/en not_active Abandoned
- 2021-07-20 CA CA3186826A patent/CA3186826A1/en active Pending
- 2021-07-20 EP EP21845856.0A patent/EP4185319A4/en active Pending
-
2023
- 2023-01-20 US US18/157,589 patent/US20230321281A1/en active Pending